Effect of Mindfulness Training on the Clinical Pregnancy Rate in Women Undergoing Frozen Embryo Transfer: Study Protocol for a Single-Center, Open-Label, Randomized Controlled Trial Authors: Songping Yi, Junyan Zhang, Aimin Li, Na Zhou, Jing Li, Ruxue Cao, Yuan Gao, Xiaolei Liu, Jiajia Zhai Published: 2026 ABSTRACT AbstractObjectiveTo evaluate the effect of mindfulness training in addition to essential psychological counseling on the clinical pregnancy rate in women undergoing frozen embryo transfer (FET), and to explore the potential mediating role of neuropsychological improvements.Methods and AnalysisThis study will be conducted as a single-center, parallel-group, open-label, exploratory randomized controlled trial. Eligible women aged 18–45 years undergoing FET who present with psychological distress (mild to moderate anxiety symptoms, depressive symptoms, poor sleep quality, or psychosocial stress overload) will be recruited. Participants will be randomly assigned in a 1:1 ratio to either the Mindfulness Training Group (MTG), which delivers structured formal mindfulness practice, or the Essential Psychological Counseling Group (EPCG), which provides supportive psychoeducation and emotional guidance without mindfulness-based training. The primary endpoint will be the clinical pregnancy rate. Secondary endpoints include changes in anxiety symptoms, depressive symptom, sleep quality, and psychosocial stress; the live birth rate will be assessed exploratorily. Mediation analyses will be performed to assess whether neuropsychological improvements explain the relationship between mindfulness training and clinical pregnancy. A total of 434 participants will be enrolled, allowing for a 20% dropout rate.Trial RegistrationThis trial is registered with the Chinese Clinical Trial Registry (ChiCTR2600116827).Keywords: mindfulness, psychological distress, clinical pregnancy, frozen embryo transfer, randomized controlled trial Background Against the backdrop of the growing global burden of infertility, assisted reproductive technology (ART) has become an essential therapeutic approach. Frozen embryo transfer (FET) is widely applied in contemporary ART practice because of its procedural flexibility, favorable safety profile, and stable reproductive outcomes. However, despite continuous technical refinements, improvements in clinical pregnancy rates following FET remain limited, highlighting persistent challenges in treatment optimization.1 Current evidence suggests that endometrial receptivity after embryo transfer is a critical determinant of FET success, and growing attention has therefore been directed toward factors that may influence this process, including psychological stress in women undergoing in vitro fertilization (IVF).2 During treatment, patients commonly experience cumulative stress arising from medical procedures, psychosocial pressures related to infertility, and uncertainty surrounding pregnancy outcomes.3,4 Prolonged or excessive stress has been shown to interfere with reproductive function through integrated neuroendocrine and immune-related processes, thereby potentially compromising reproductive physiology and implantation conditions.5,6 Clinical and epidemiological studies have consistently reported associations between elevated psychological distress and adverse reproductive outcomes, including increased risk of miscarriage and reduced likelihood of achieving clinical pregnancy.7–9 In parallel, sleep disturbances, which frequently coexist with psychological stress during fertility treatment, have also been linked to altered reproductive outcomes, further supporting the relevance of neuropsychological factors in the reproductive microenvironment.10 Mindfulness training, as an evidence-based psychological intervention, has been increasingly explored for its potential to improve health outcomes under conditions of sustained stress. Mindfulness-based interventions are associated with small to moderate improvements in stress and psychological outcomes, some of which appear to be sustained over time.11 In addition to stress regulation, emerging research indicates that mindfulness-based interventions may be associated with broader biological adaptations relevant to reproductive health, although the underlying mechanisms remain incompletely characterized.12 Together, these effects may be relevant to outcomes of assisted reproductive treatment. Within reproductive medicine, mindfulness interventions have been proposed as a supportive strategy capable of modulating stress responses and improving overall psychological well-being during fertility treatment.13 Although a systematic review reported an overall improvement in pregnancy rates associated with psychological interventions across infertile populations, regardless of intervention characteristics, the included trials were not specifically designed for women with clinically defined neuropsychological distress undergoing assisted reproductive treatment.14 Against this background, the present study is designed to evaluate the impact of mindfulness training on clinical pregnancy rates in women undergoing IVF with FET who exhibit neuropsychological distress. In addition, this randomized controlled trial is designed to evaluate whether mindfulness training can improve the clinical pregnancy rate (CPR) in women with neuropsychological distress or allostatic overload undergoing FET, potentially through concurrent improvements in anxiety symptoms, depressive symptoms, sleep quality, and psychosocial stress. Methods Study Design and Grouping This study is a single-center, parallel, open-label, exploratory randomized controlled trial, conducted in accordance with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines.15 Eligible participants will be randomly assigned to the Mindfulness Training Group (MTG), which will receive mindfulness training in addition to Essential Psychological Counseling Group (EPCG), which will receive Essential Psychological Counseling only (Figure 1). Overall Study Design Across the Screening, Core, and Extension Phases. Notes: Arrows indicate the chronological flow of study procedures and participant progression. Shaded areas represent the predefined study phases, including the Screening Phase, Core Phase, and Extension Phase. Participants were randomized to either the Mindfulness Training Group or the Essential Psychological Counseling Group during the core phase. Clinical pregnancy outcomes determined progression to the extension phase for live birth follow-up. Abbreviations: MTG, Mindfulness Training Group; EPC, Essential Psychological Counseling; EPCG, Essential Psychological Counseling Group; CP, Clinical Pregnancy; LB, Live Birth. Recruitment will be conducted among women scheduled for FET. Eligible candidates will be women aged 18–45 years who present with indicators of psychological distress, such as mild to moderate anxiety symptoms, depressive symptoms, poor sleep quality, or psychosocial stress overload. Screening procedures will combine review of clinical records with standardized psychological evaluations. Women fulfilling the eligibility criteria will be invited to participate and asked to sign written informed consent before randomization. The overall study flow is presented in Figure 1, and the intervention schedule is summarized in Table 1. Table 1Time Schedule of the Trial Process (Core Phase)BeforeImplementationDay ofImplementationAfter ImplementationWeek 1Week 2Week 3Week 4Enrollment Eligibility screen× SIC× TIC× Demographics× Diagnosis× Infertility history×Laboratory Test Biochemical pregnancy (serum HCG)× Estradiol× Follicle-stimulating hormone× Luteinizing hormone× Progesterone× Prolactin× Testosterone× Blood lipid× Fasting blood glucose× Liver function× Renal function× Thyroid function×Electrocardiogram×Chest X ray×Randomization×Implementation×Standard Post-IVF Outpatient Visits××Ultrasound monitoring Endometrial thickness× Clinical pregnancy (gestational sacs)×Neuropsychological Assessments GAD-7×× PHQ-9×× PSQI×× PSI×Intervention××××Complications××××Abbreviations: SIC, Screening Informed Consent; TIC, Trial Informed Consent; HCG, human chorionic gonadotropin; GAD-7, Generalized Anxiety Disorder 7-item scale; PHQ-9, Patient Health Questionnaire-9; PSQI, Pittsburgh Sleep Quality Index; PSI, PsychoSocial Index. Time Schedule of the Trial Process (Core Phase) Abbreviations: SIC, Screening Informed Consent; TIC, Trial Informed Consent; HCG, human chorionic gonadotropin; GAD-7, Generalized Anxiety Disorder 7-item scale; PHQ-9, Patient Health Questionnaire-9; PSQI, Pittsburgh Sleep Quality Index; PSI, PsychoSocial Index. Neuropsychological Assessments In this study, anxiety symptoms will be assessed using the Generalized Anxiety Disorder 7-item scale (GAD-7),16,17 depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9),16,18,19 sleep will be using the Pittsburgh Sleep Quality Index (PSQI),20 and stress is assessed using the PsychoSocial Index (PSI).21,22 The Chinese versions of these questionnaires are available.23–26 Study Phases and Corresponding Objectives The screening phase is designed to identify eligible participants with neuropsychological distress. After provision of screening informed consent, baseline neuropsychological assessments will be conducted to determine eligibility, followed by trial informed consent for participants who meet the inclusion criteria before randomization (Figure 1). The core phase includes a standardized 4-week intervention period for all randomized participants, followed by clinical pregnancy assessment according to routine clinical practice. Because the timing of ultrasound confirmation of clinical pregnancy may vary across individuals, the final outcome ascertainment may occur approximately 5–6 weeks after embryo transfer (Figure 1). The extension phase focuses on longer-term outcomes beyond early pregnancy. Participants who achieve clinical pregnancy will be followed to assess live birth outcomes and sustained changes in psychosocial stress, enabling exploratory evaluation of longer-term intervention effects over approximately 33–35 weeks after embryo transfer (Figure 1). Endpoints The primary endpoint of the core phase is the proportion of participants achieving clinical pregnancy in each group. The secondary endpoints include changes in GAD-7, PHQ-9, and PSQI from baseline to the end of the core phase, as well as changes in PSI from baseline to the end of the extension phase. The exploratory endpoints include the live birth rate. Exploratory analyses will further assess the direct effect of mindfulness training on clinical pregnancy and its potential mediating effects through improvements in anxiety, depression, and sleep quality. Inclusion Criteria Female aged 18 to 45 years who will undergo IVF-FET for any cause of infertility; Female aged 18 to 45 years who will undergo IVF-FET for any cause of infertility; Both spouses are permanent residents of the same province where the study hospital is located; Both spouses are permanent residents of the same province where the study hospital is located; Female has either a GAD-7 score of 5–14,27 a PHQ-9 score of 5–14,27 a PSQI score of 5–10,28 or evidence of allostatic overload as assessed by PSI;29 Female has either a GAD-7 score of 5–14,27 a PHQ-9 score of 5–14,27 a PSQI score of 5–10,28 or evidence of allostatic overload as assessed by PSI;29 Both spouses are willing to participate in the study and will provide written informed consent. Both spouses are willing to participate in the study and will provide written informed consent. Exclusion Criteria Participation in other clinical studies within 3 months prior to screening; Participation in other clinical studies within 3 months prior to screening; History of severe violent tendencies; History of severe violent tendencies; Comorbid severe or unstable cardiovascular, respiratory, hepatic, renal, hematological, endocrine, neurological, or other systemic diseases; Comorbid severe or unstable cardiovascular, respiratory, hepatic, renal, hematological, endocrine, neurological, or other systemic diseases; Inability to cooperate with relevant examinations; Inability to cooperate with relevant examinations; Planned relocation to another city from enrollment until 3 weeks after the expected due date. Planned relocation to another city from enrollment until 3 weeks after the expected due date. Criteria for Study Discontinuation and Phase Transition Withdrawal of informed consent by the participant; Withdrawal of informed consent by the participant; Inability to tolerate interventions; Inability to tolerate interventions; Loss to follow-up; Loss to follow-up; Noncompliance with the randomized assignment, such as crossover between groups; Noncompliance with the randomized assignment, such as crossover between groups; Absence of biochemical pregnancy after embryo transfer, precluding subsequent clinical pregnancy assessment. Absence of biochemical pregnancy after embryo transfer, precluding subsequent clinical pregnancy assessment. Participants meeting criteria 4 or 5 may continue to receive the assigned intervention according to their original group allocation. In all five situations, outcomes will be analyzed as clinical pregnancy failure in the group to which the participant was originally randomized. Study Procedures Screening and Neuropsychological Assessment Potential participants scheduled for frozen embryo transfer will first be invited to sign a Screening Informed Consent (SIC), indicating their agreement to undergo screening procedures. After providing SIC, participants will complete baseline neuropsychological assessments as part of the screening process, including GAD-7, PHQ-9, PSQI, and PSI. These assessments will be administered face-to-face by scanning a QR code on a smartphone, and data will be uploaded to a secure backend system for evaluation. All assessments will be conducted by trained physicians or nurses and led by a qualified neurologist with subspecialty expertise in neuropsychology. Participants who meet the predefined inclusion and exclusion criteria based on the screening assessments will then be invited to sign the Trial Informed Consent (TIC) for participation in the randomized controlled trial. Only participants who have provided TIC will proceed to randomization. Eligible and consented participants will subsequently be enrolled and randomized to the assigned intervention groups. Randomization and Blinding Allocation Randomization will be conducted by an independent statistical party. Participants will be enrolled by the investigators and then assigned sequentially according to the predetermined random sequence. If an individual withdraws informed consent immediately after allocation and before receiving any study intervention or completing any post-randomization assessment, no further study procedures will be performed. Such cases will be documented as post-randomization withdrawal before intervention initiation. The randomization record will be retained, and any replacement or additional recruitment, if required to maintain the planned sample size, will use the next allocation in the prespecified randomization sequence rather than invalidating or reusing the original allocation. Concealment To ensure standardization of the grouping procedure and to minimize the risk of selection bias, allocation concealment will be strictly maintained. The complete randomization list will be stored in an encrypted electronic file and will be independently preserved by the statistical party. After each participant completes screening and eligibility is confirmed, the research team will notify the statistical party. According to the predetermined randomization sequence, the statistical party will then verify the allocation and return the group assignment to the investigator. During the entire process, recruitment and assessment personnel will remain blinded to upcoming allocations, thereby ensuring effective allocation concealment, reducing potential selection bias, and maintaining the internal validity of the trial. Any modification of the randomization scheme is strictly prohibited. Blinding Because the interventions involve mindfulness training (MT) and essential psychological counseling (EPC), blinding is not feasible in this study. Avoidance of Contamination In the outpatient setting, participants undergoing IVF may exchange information with each other. To minimize the risk of information contamination between groups, standard post-IVF outpatient visits will be scheduled on different days for participants assigned to different interventions. These follow-up visits are part of the standard care required after IVF and will be arranged accordingly. This arrangement does not alter the standard medical care procedures. Interventions All participants, once randomized, will receive the assigned interventions as outlined in Figure 2. Flow of Intervention Procedures During the Core Phase. Notes: Arrows indicate the chronological flow of participant progression and intervention procedures during the core phase. Shaded boxes indicate the intervention pathways after randomization. Participants without biochemical pregnancy discontinued the intervention according to the predefined study procedures, whereas those achieving clinical pregnancy proceeded to outcome assessment. Abbreviations: R, Randomization; MT, Mindfulness Training; MTG, Mindfulness Training Group; EPC, Essential Psychological Counseling; EPCG, Essential Psychological Counseling Group; BP, Biochemical Pregnancy; CP, Clinical Pregnancy. Essential Psychological Counseling As a standardized background intervention, all randomized participants in both study groups will receive the same EPC program throughout the core phase. Participants will access the stress-reduction training program by scanning a QR code via WeChat, which will direct them to the designated online platform. The EPC program consists of self-guided stress-reduction modules designed to support emotional regulation, stress coping, and psychological adaptation during frozen embryo transfer. Participants may freely select training modules according to their personal preferences, without restrictions on module selection, training duration, session frequency, or overall schedule. The program includes structured modules across three progressive levels (introductory, intermediate, and advanced), including mindful listening, body scan, stretching, mindful walking, awareness of thoughts and emotions, imagery-based meditation (mountain, sea, lake), loving-kindness practice, and sitting meditation (Table 2). All modules will be accompanied by voice guidance and soothing background music. Table 2Training Modules of the Mindfulness Intervention ProgramLevelCourse NameBrief DescriptionIntroductory 1Introduction to Stress-Reduction PracticeProvides an overview and orientation for stress-reduction exercises. 2Raisin Exercise (1)Classic mindfulness exercise focusing on awareness of eating. 3Raisin Exercise (2)Continuation of mindful eating practice. 4.1Breathing Awareness Exercise (1)Introductory practice on mindful breathing. 4.2Breathing Awareness Exercise (2)Extended practice on breathing awareness. 5Three-Minute Breathing SpaceBrief mindfulness technique to enhance present-moment awareness.Intermediate 1Mindful ListeningPractice of attentive and non-judgmental listening. 2Body ScanProgressive attention to bodily sensations. 3Mindful StretchingGentle stretching with mindful awareness. 4Mindful WalkingWalking meditation with attention to movement and surroundings. 5Awareness of Thoughts and EmotionsCultivating observation of cognitive and emotional processes.Advanced 1Mountain MeditationGuided imagery focusing on stability and resilience. 2Ocean MeditationGuided imagery emphasizing calmness and flow. 3Loving-Kindness PracticeMeditation cultivating compassion and kindness. 4Lake MeditationVisualization practice fostering clarity and stillness. 5Sitting MeditationExtended mindfulness meditation in sitting posture. Training Modules of the Mindfulness Intervention Program The platform’s backend system will automatically record each participant’s training engagement, including the modules accessed, the frequency of participation, and the duration of each session. These data will be used to ensure accurate monitoring of adherence and exposure to the intervention throughout the study period. All data will be stored securely and used exclusively for research purposes. In addition, all participants will be able to discuss pregnancy-related issues with their physicians, and such communication with doctors will help alleviate neuropsychological concerns. Mindfulness Training In addition to the essential psychological counseling, participants of MTG will receive an integrated mindfulness training program,30 with the specific process detailed in Figure 3. The mindfulness training will be delivered through instructor-guided online sessions conducted twice weekly over a four-week period. Structure of the Four-Week Mindfulness Training Program. Notes: Arrows indicate the chronological progression of the mindfulness training program across the four intervention weeks. Shaded boxes indicate the weekly mindfulness training blocks, with two sessions scheduled each week according to the predefined intervention protocol. Each week includes specific mindfulness practices delivered in sequential sessions. Abbreviation: MT, Mindfulness Training. The mindfulness method is based on the literature30 with appropriate adaptations, as follows: Weekly centralized sessions covering various formal meditation techniques, including seated meditation, body sweep/body scan, mindful yoga movements, and walking meditation. Each session will include approximately 30 minutes of live guided instruction and supervised practice. Outside of class, participants are also required to integrate these mindfulness practices into daily life and persist with home practice. In most studies, the total practice time is approximately 28 hours, distributed across these 8 sessions; additionally, participants are required to perform daily independent guided practice using provided 30-minute audio CDs, which is recorded. Participants will also be encouraged to continue self-directed home practice using recorded materials between guided sessions and to integrate mindfulness practices into daily life. The present study adopts a flexible remotely delivered format to improve feasibility and adherence during the relatively limited clinical window between embryo transfer and clinical pregnancy assessment. In addition, the online platform will automatically record participants’ engagement with recorded materials, including access frequency and practice duration, to facilitate monitoring of intervention adherence throughout the study period. Data Collection and Management Before Randomization Before randomization, all participants will undergo baseline neuropsychological assessments using the GAD-7, PHQ-9, PSQI, and PSI, which will serve both for eligibility screening and as baseline measurements. After Randomization Baseline Characteristics After randomization, baseline characteristics will be recorded for each participant, including age, body mass index (BMI), years of education, duration of infertility, smoking and alcohol use, comorbidities (eg, hypertension, diabetes, chronic kidney disease), and parity. Baseline Laboratory Tests Serum levels of follicle-stimulating hormone (FSH, μIU/mL), luteinizing hormone (LH, μIU/mL), estradiol (E2, pg/mL), progesterone (P, ng/mL), testosterone (T, ng/mL), and prolactin (PRL, ng/mL) will be measured using commercial kits (Siemens Healthcare Diagnostics) with an automatic chemiluminescence immunoassay analyzer. In addition, thyroid function, fasting blood glucose, liver function, renal function, and blood lipid profiles will be assessed. Baseline Imaging and Instrumental Examinations Routine clinical examinations, including electrocardiogram and chest X-ray, will be performed. Transvaginal ultrasound will be used to assess endometrial thickness. Follow-Up Assessments Biochemical pregnancy will be assessed by serum human chorionic gonadotropin (hCG) at 2 weeks after embryo transfer. Clinical pregnancy will be confirmed by the presence of gestational sacs on ultrasound at 4 weeks. Neuropsychological assessments, including GAD-7, PHQ-9, and PSQI, will be repeated at the end of week 4. Reporting Summary and Data Preservation All study data will be collected, managed, and archived in accordance with Good Clinical Practice guidelines. Source documents, electronic case report forms, informed consent forms, and laboratory records will be securely stored and made available for monitoring, auditing, and regulatory inspection. All study records will be retained for at least 5 years after study completion. Statistical Analysis Descriptive Statistics Continuous variables will be described as the mean with standard deviation (SD) for normally distributed data, or as the median with interquartile range (IQR) presented as the 1st quartile to the 3rd quartile (Q1-Q3) for non-normally distributed data. The Student’s t-test was applied for normally distributed data, while the Mann–Whitney test was employed for data with non-normal distributions. Categorical variables were represented as counts and percentages. The statistical significance of categorical variables was assessed using Pearson’s chi-square test or Fisher’s exact test. Statistical Inference Primary Endpoint For the primary endpoint, multivariable logistic regression will be performed if covariate adjustment is required. Variables with p ≤ 0.10 in univariate analyses will be considered as candidate variables for the initial multivariable model.31,32 A backward stepwise selection procedure will then be applied, and variables will be retained in the final model if they remain statistically relevant during model selection. In addition, clinically important baseline variables with established associations with reproductive outcomes, such as age, body mass index, and duration of infertility, may be retained regardless of their univariate p-values to ensure clinical interpretability of the model. Odds ratios (ORs) and 95% confidence intervals (CIs) will be reported. All p-values below 0.05 were considered statistically significant. Secondary Endpoint The secondary endpoints including the changes of GAD-7, PHQ-9, PSQI from baseline to the end of the core phase, and PSI changes from the baseline to the end of extension phase. Between-group differences will be expressed as mean (SD) or median (IQR), depending on the data distribution. These analysis will not be adjusted for covariates in multivariate analyses, nor will they be included in considerations of α inflation. The resulting p-values will be reported as nominal and will not be interpreted as statistical inference. Exploratory Endpoints The exploratory endpoints include evaluation of the direct effect of mindfulness training on the CPR and its potential indirect effects mediated through changes in anxiety symptoms, depressive symptoms, sleep quality, and allostatic overload. Causal mediation analysis based on the counterfactual framework will be applied to decompose the total effect into natural direct and indirect effects, with appropriate adjustment for relevant covariates. Analysis Datasets This study will perform statistical analyses using both the Intention-To-Treat (ITT) dataset and the Per-Protocol (PP) dataset. The ITT dataset analysis will include participants who change groups or discontinue participation during the study, with their endpoint considered as no clinical pregnancy. Participants lost to follow-up will also be regarded as having no clinical pregnancy. The ITT dataset will provide the primary results of the study, while the PP dataset analysis, conducted based on the groups to which participants actually belonged and limited to those who completed the study, will serve as a sensitivity analysis to corroborate the ITT findings. Sample Size Consideration The CPR in the MTG was estimated at 55% based on findings from a representative randomized trial.33 Considering the documented adverse effects of neuropsychological distress on reproductive outcomes, the CPR in the EPCG was conservatively estimated at 40%. The α level was set at 0.05 (two-sided), with a statistical power of 80% (β = 0.2). Allowing for a 20% dropout rate, approximately 217 participants were required per group, resulting in a planned total sample size of 434 participants corresponds to 217 participants in each study group. Discussion Previous studies have suggested that mindfulness-based interventions may influence stress-related neuroendocrine regulation, including hypothalamic-pituitary-adrenal axis activity, which may be relevant to reproductive physiology and endometrial receptivity.34,35 However, whether a relatively short-term intervention delivered during the limited peri-transfer window can translate into measurable improvements in reproductive outcomes remains incompletely understood. The present trial therefore further explores the potential relationship between mindfulness-associated neuropsychological improvement and reproductive outcomes in women undergoing frozen embryo transfer. This study is designed to evaluate the potential effect of mindfulness training on clinical pregnancy outcomes in women undergoing frozen embryo transfer who present with psychological distress or allostatic overload. Unlike previous mindfulness-related studies in assisted reproduction, which have primarily focused on general psychological symptoms or self-reported well-being in unselected infertility populations, the present trial specifically targets women with psychological distress or allostatic overload, evaluates clinical pregnancy as the primary reproductive endpoint, and further explores potential neuropsychological mediation pathways under real-world clinical conditions. By integrating reproductive outcomes with standardized neuropsychological assessments and planned mediation analyses, this trial may provide new evidence regarding whether improvements in anxiety symptoms, depressive symptoms, sleep quality, and psychosocial stress are associated with clinical pregnancy outcomes in this specific population. As a pragmatic behavioral intervention conducted under real-world clinical conditions, this study also has several inherent limitations. Because of the behavioral nature of mindfulness training, participant blinding is not feasible, which may influence self-reported psychological outcomes through expectancy effects and other non-specific intervention effects, although the primary reproductive endpoint is based on objective clinical assessment. In addition, participants in the MTG may receive greater structured interaction and guided engagement through instructor-guided online mindfulness sessions beyond the mindfulness-specific components of the intervention. Therefore, if between-group differences are observed, it may not be possible to completely distinguish mindfulness-specific effects from non-specific effects related to intervention engagement and interpersonal interaction. Furthermore, although follow-up visits for participants assigned to different interventions will be scheduled on separate days to reduce the risk of information exchange, residual contamination between groups cannot be completely excluded, particularly in the context of digital communication and social media among patients undergoing IVF treatment. These limitations should be considered when interpreting the findings, and future studies using attention-matched control designs may further help isolate mindfulness-specific effects. Conclusion This trial is expected to provide clinically relevant evidence for integrating structured psychological interventions into routine assisted reproductive care. Specifically, this study will evaluate whether the addition of structured mindfulness training to standardized background psychological support is associated with improved clinical pregnancy outcomes during the core phase and subsequent live birth outcomes during extension-phase follow-up, while also exploring potential improvements in psychological well-being during treatment. By addressing the current lack of high-quality randomized evidence in this area, this study may help bridge an important gap in the existing literature and inform future clinical practice. Funding Statement National Natural Science Foundation of China (82560282 to X.L); The 2025 Annual Medical Science Research of Health Commission of Hebei Province (20250555 to J.Zhai). Declaration of Generative AI and AI-Assisted Technologies in the Writing Process The authors used ChatGPT to assist with language polishing and to improve the clarity and readability of the manuscript. All content generated with the assistance of this tool was subsequently reviewed and revised by the authors, who take full responsibility for the final version of the publication. Ethics of the Clinical Research The study will be conducted in accordance with the Declaration of Helsinki of the World Medical Association and all other applicable regulations. The study protocol has been approved by the Institutional Review Board (Ethics Committee) of the Second Hospital of Hebei Medical University (approval number 2025-R790-X1). Prior to enrollment, the investigator will fully explain the objectives, procedures, and potential risks of the study to each participant or their legal representative, and written informed consent will be obtained. Participants will be informed of their right to withdraw from the study at any time without penalty. All informed consent forms will be retained as official clinical research documents. Participant privacy and data confidentiality will be strictly protected and maintained throughout the entire study period. In addition, this study has been registered with the Chinese Clinical Trial Registry36 under registration number ChiCTR2600116827. Disclosure The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. References